Overview

Pregabalin In Adolescent Patients With Fibromyalgia

Status:
Completed

Trial end date:
2015-06-01

Target enrollment:
0

Participant gender:
All

Summary

The main purpose of this study is to evaluate the long-term safety of pregabalin in adolescent patients who participated in the previous fibromyalgia study (A0081180) and who wish to recieve open-label pregabalin

Phase:

Phase 4

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Treatments:

Pregabalin

Criteria

Inclusion Criteria:

- Patients must have met the inclusion criteria for the preceding fibromyalgia Study
A0081180, and have received pregabalin/placebo under double-blind conditions.

Exclusion Criteria:

- Patients may not participate in the study if they experienced a serious adverse event
during the previous fibromyalgia study A0081180 which was determined to be related to
the study medication by the investigator or sponsor.